Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Preston Mason

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2006
Targeting nitric oxide with drug therapyR Preston Mason, John R Cockcroft
The Journal of Biological Chemistry|October 1, 2005
Lipid peroxidation induces cholesterol domain formation in model membranesRobert F Jacob, R Preston Mason
Lipids in Health and Disease|February 1, 2017
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)Eliot A Brinton, R Preston Mason
Atherosclerosis|June 13, 2003
Inhibition of oxidized LDL aggregation with the calcium channel blocker amlodipine: role of electrostatic interactionsJane Ellen Phillips, R Preston Mason
Biochimica Et Biophysica Acta|December 3, 2014
Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanismR Preston Mason, Robert F Jacob
The American Journal of Medicine|April 17, 2021
Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk ReductionR Preston Mason, Robert H Eckel
Pharmacology & Therapeutics|June 30, 2022
Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acidM John Chapman, R Preston Mason
Biochemical and Biophysical Research Communications|December 25, 2016
Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefitsR Preston Mason, Samuel C R Sherratt
Chemistry and Physics of Lipids|January 23, 2018
Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffractionSamuel C R Sherratt, R Preston Mason
Biochemical and Biophysical Research Communications|January 15, 2018
Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acidSamuel C R Sherratt, R Preston Mason
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2006
Targeting nitric oxide with drug therapyR Preston Mason, John R Cockcroft
The Journal of Biological Chemistry|October 1, 2005
Lipid peroxidation induces cholesterol domain formation in model membranesRobert F Jacob, R Preston Mason
Lipids in Health and Disease|February 1, 2017
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)Eliot A Brinton, R Preston Mason
Atherosclerosis|June 13, 2003
Inhibition of oxidized LDL aggregation with the calcium channel blocker amlodipine: role of electrostatic interactionsJane Ellen Phillips, R Preston Mason
Biochimica Et Biophysica Acta|December 3, 2014
Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanismR Preston Mason, Robert F Jacob
The American Journal of Medicine|April 17, 2021
Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk ReductionR Preston Mason, Robert H Eckel
Pharmacology & Therapeutics|June 30, 2022
Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acidM John Chapman, R Preston Mason
Biochemical and Biophysical Research Communications|December 25, 2016
Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefitsR Preston Mason, Samuel C R Sherratt
Chemistry and Physics of Lipids|January 23, 2018
Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffractionSamuel C R Sherratt, R Preston Mason
Biochemical and Biophysical Research Communications|January 15, 2018
Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acidSamuel C R Sherratt, R Preston Mason
Pageof 10